79.48
Bright Minds Biosciences Inc (DRUG) 最新ニュース
BTIG Research Reiterates "Buy" Rating for Bright Minds Biosciences (NASDAQ:DRUG) - MarketBeat
Liquidity Mapping Around (DRUG) Price Events - Stock Traders Daily
Bright Minds Biosciences (NASDAQ:DRUG) Issues Quarterly Earnings Results - MarketBeat
Bright Minds (DRUG) reports Phase 2 seizure gains in treatment‑resistant epilepsy - Stock Titan
Bright Minds Biosciences (DRUG): Cormorant Asset Management reports 9.17% ownership stake - Stock Titan
Can Bright Minds (TSX:DRUG) Keep Biotech Momentum Going? - Kalkine Media
Adage Capital (DRUG) discloses 3.41% Bright Minds Biosciences stake in latest holding - Stock Titan
Bright Minds Biosciences Inc. expected to post a loss of C$1.76 a shareEarnings Preview - TradingView
Wall Street Analysts Think Bright Minds Biosciences Inc. (DRUG) Could Surge 97.4%: Read This Before Placing a Bet - Yahoo Finance
Bright Minds Biosciences Inc (CN:DRUG) Shares Under Pressure as Biotech Sentiment Weakens and Development Risks Increase - kalkine.ca
Bright Minds: BMB-101 Takes Center Stage Ahead Of Phase 3 Pivotal Trials (NASDAQ:DRUG) - Seeking Alpha
Bright Minds Biosciences (CN:DRUG): The Ticker Everyone's Talking About After a US$175M Raise and a Seizure Data Bombshell - kalkine.ca
Bright Minds Biosciences Inc (CN:DRUG) Jumps 4.05%: neuroscience biotech's Canadian line rose to C$114 on almost no volume, a thin-trading blip rather than - kalkine.ca
Bright Minds Biosciences (DRUG) to Post Quarterly Earnings on Thursday - MarketBeat
Why (DRUG) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Perceptive Advisors LLC Sells 71,746 Shares of Bright Minds Biosciences Inc. $DRUG - MarketBeat
Janus Henderson Group PLC Raises Holdings in Bright Minds Biosciences Inc. $DRUG - MarketBeat
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
ADAR1 Capital Management LLC Has $2.47 Million Stock Position in Bright Minds Biosciences Inc. $DRUG - MarketBeat
Bright Minds Biosciences Inc (DRUG) Cash Flow - TradingKey
40,000 Shares in Bright Minds Biosciences Inc. $DRUG Acquired by Orbimed Advisors LLC - MarketBeat
Bright Minds Biosciences Inc (DRUG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bright Minds Biosciences Inc (DRUG) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bright Minds Biosciences Inc (DRUG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bright Minds Biosciences Inc (DRUG) Institutional Confidence - TradingKey
DRUG|Bright Minds Biosciences Inc|Price:71.840|Chg%:+0.510 - TradingKey
Bright Minds Biosciences Inc (DRUG) Balance Sheet - TradingKey
Wall Street Analysts See a 107.53% Upside in Bright Minds Biosciences Inc. (DRUG): Can the Stock Really Move This High? - Yahoo Finance
Wall Street Analysts See a 27.16% Upside in Unity Software (U): Can the Stock Really Move This High? - Zacks Investment Research
Walleye Capital LLC Has $3.92 Million Holdings in Bright Minds Biosciences Inc. $DRUG - MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) Upgraded at Zacks Research - MarketBeat
All You Need to Know About Bright Minds Biosciences Inc. (DRUG) Rating Upgrade to Strong Buy - Yahoo Finance
Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
Bright Minds Biosciences (DRUG) Rallies 4.25% as Shares Approach Key ResistanceSwing Entry Signals - dars.gov.et
Bright Minds Biosciences (NASDAQ:DRUG) Shares Up 5%Should You Buy? - MarketBeat
Eli Lilly deal to buy AtaiBeckley (psychedelic) - KuCoin
Wall Street Analysts See a 27.35% Upside in Harmony Biosciences (HRMY): Can the Stock Really Move This High? - Yahoo Finance
Bright Minds Biosciences (DRUG) Climbs 2.55% as Bullish Momentum Builds Near Key ResistanceConversion Trade - dars.gov.et
Draig bags another $65M to speed testing of brain drugs - Yahoo Finance
Understanding Momentum Shifts in (DRUG) - Stock Traders Daily
Bright Minds Biosciences (DRUG) Faces Modest Pullback Amid Sector ConsolidationBPI Bear Confirmed - dars.gov.et
Bright Minds Biosciences (NASDAQ:DRUG) Shares Down 7.7%What's Next? - MarketBeat
Bright Minds Biosciences Inc Company Profile & Introduction - Moomoo
Epilepsy Pipeline Expands as 75+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
Form 13D/A BRIGHT MINDS BIOSCIENCES INC. For: 2 July By Investing.com - Investing.com Canada
Ian McDonald reports 13.6% Bright Minds (DRUG) ownership stake - Stock Titan
Best TSX Healthcare Stocks to Watch for July 2026 - Kalkine Media
Avoiding Lag: Real-Time Signals in (DRUG) Movement - Stock Traders Daily
Canadian Securities Exchange Reports January 2026 Performance Figures - The Canadian Securities Exchange (CSE)
Bright Minds Biosciences (DRUG) Surges 3.51%, Testing Resistance at $75.19Equity Put Call - dars.gov.et
Indivior Pharmaceuticals Inc. (INDV) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
BrightSpring Health Services, Inc. (BTSG) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
Bright Minds Biosciences Inc (DRUG) Stock Forum and Discussion - Moomoo
Bright Minds Biosciences (DRUG) Surges 3.38% as Shares Approach Resistance at $69.08Diagonal Spread Trade - po-news-eg.net
DRUG Forecast — Price Target — Prediction for 2027 - TradingView
Bright Minds Biosciences Inc. Actuals & Estimates (CSE:DRUG) - TradingView
Bright Minds Biosciences Inc. (DRUG) Shows Modest Uptick, Testing Key ResistanceGap Fill Strategy - dars.gov.et
$ENA Forecast — Price Prediction for 2026. Should I Buy $ENA? - Intellectia AI
Bright Minds Biosciences (DRUG) Edges Lower Near Resistance Amid Quiet TradingCash Flow Strong Stocks - dars.gov.et
DRUG Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Income Statement - Intellectia AI
DRUG Technical Analysis & Stock Price Forecast - Intellectia AI
Discipline and Rules-Based Execution in DRUG Response - Stock Traders Daily
大文字化:
|
ボリューム (24 時間):